All Stories

  1. Effects of Advanced Glycation End Products via Oxidative Stress on Beta Cells: Insights from in vitro and in vivo Studies and Update on Emerging Therapies
  2. Highlights from the 82nd ADA Scientific Sessions and the 58th EASD Meeting on Diabetic Neuropathy
  3. Impact of Glucagon-like peptide 1 receptor agonists on peripheral arterial disease in people with diabetes mellitus: A narrative review
  4. Acute effect of coffee consumption on blood pressure, QTc interval, and heart rate variability in people with type 2 diabetes
  5. Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study
  6. Diabetes mellitus and multiple myeloma; common features of two distinct entities
  7. Low concentrations of bisphenol A promote the activation of the mitochondrial apoptotic pathway on Beta‐TC‐6 cells via the generation of intracellular reactive oxygen species and mitochondrial superoxide
  8. Lipidomics Analysis of Free Fatty Acids in Human Plasma of Healthy and Diabetic Subjects by Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS)
  9. Immunogenicity of SARS-CoV-2 BNT162b2 Vaccine in People with Diabetes: A Prospective Observational Study
  10. The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID‐19 patients. A systematic review, meta‐analysis and meta‐regression
  11. The glycemic status determines the direction of the relationship between red cell distribution width and HbA1c
  12. Editorial: Understanding Diabetic Foot Disease: Current Status and Emerging Treatment Approaches
  13. Rare diabetic neuropathies: It is not only distal symmetrical polyneuropathy
  14. Therapeutic Properties of Honey for the Management of Wounds; Is There a Role in the Armamentarium of Diabetic Foot Ulcer Treatment? Results From In vitro and In vivo Studies
  15. The use of L-glucose in cancer diagnosis: Results from In Vitro and In Vivo Studies
  16. Early left ventricular systolic dysfunction in asymptomatic patients with type 1 diabetes: a single-center, pilot study
  17. The Performance and Interrater Agreement of Vibration Perception for the Diagnosis of Loss of Protective Sensation in People With Diabetes Mellitus
  18. Evaluation of Vitamin D Levels in Patients With Diabetic Foot Ulcers
  19. Adoption of and adherence to the Hellenic Diabetes Association guidelines for the management of subjects with type 2 diabetes mellitus by Greek physicians
  20. Nonpharmacological Management of Diabetic Foot Ulcers: An Update
  21. Factors associated with sclerostin levels – A calcification inhibitor – In individuals with type 2 diabetes mellitus; Is autonomic neuropathy the missing link?
  22. Dryness of Foot Skin Assessed by the Visual Indicator Test and Risk of Diabetic Foot Ulceration: A Prospective Observational Study
  23. Telomere length, epidemiology and pathogenesis of severe COVID‐19
  24. In Vitro Data of Current Therapies for SARS-CoV-2
  25. Low-Glycemic-Index/Load Desserts Decrease Glycemic and Insulinemic Response in Patients with Type 2 Diabetes Mellitus
  26. Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns
  27. Comparison of Postprandial Serum Triglyceride and Apolipoprotein B Concentrations between the Two Phases of Menstrual Cycle in Healthy Women
  28. The Effect of Oxidative Stress and Antioxidant Therapies on Pancreatic B-cell Dysfunction: Results from in Vitro and in Vivo Studies
  29. Endothelial progenitor cells and peripheral neuropathy in subjects with type 2 diabetes mellitus
  30. Endothelium as a Therapeutic Target in Diabetes Mellitus: From Basic Mechanisms to Clinical Practice
  31. Carbohydrate restriction in the morning increases weight loss effect of a hypocaloric Mediterranean type diet: a randomized, parallel group dietary intervention in overweight and obese subjects
  32. Association of Circulating Osteopontin Levels With Lower Extremity Arterial Disease in Subjects With Type 2 Diabetes Mellitus: A Cross-Sectional Observational Study
  33. Improvement of metabolic control after 3-month use of real-time continuous glucose monitoring in patients with type 1 diabetes: a multicenter study in Greece
  34. SGLT2 Inhibitors: A Review of Their Antidiabetic and Cardioprotective Effects
  35. Advancing pharmacotherapy for diabetic foot ulcers
  36. Management of diabetes mellitus and patients' attitude towards the disease: Data from a nationwide study in Greece
  37. The association of diabetic microvascular and macrovascular disease with cutaneous circulation in patients with type 2 diabetes mellitus
  38. Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia
  39. Plasma Irisin Levels in Subjects with Type 1 Diabetes: Comparison with Healthy Controls
  40. Low prevalence of rheumatoid arthritis among patients with pre-existing type 2 diabetes mellitus
  41. Diabetic Foot Infections: Update on Management
  42. The Effect of the Oral Administration of Leucine on Endothelial Function, Glucose and Insulin Concentrations in Healthy Subjects
  43. Pulse pressure amplification and cardiac autonomic dysfunction in patients with type 2 diabetes mellitus
  44. Update on Cardiovascular Effects of Older and Newer Anti-diabetic Medications
  45. Prevalence of diabetes mellitus as well as cardiac and other main comorbidities in a representative sample of the adult Greek population in comparison with the general population
  46. Effect of α-lipoic acid on symptoms and quality of life in patients with painful diabetic neuropathy
  47. Liver cirrhosis-effect on QT interval and cardiac autonomic nervous system activity
  48. Diabetogenic Effects Associated with Psychiatric Treatment
  49. Insulin degludec U100 is associated with lower risk for severe and symptomatic hypoglycemia as compared with insulin glargine U100 in subjects with type 1 diabetes
  50. Antidiabetic Drugs as Antihypertensives: New Data on the Horizon
  51. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus
  52. Diabetes mellitus doubles the risk of type 2 cardiorenal syndrome: results from the NHANES trial
  53. Cardiac Autonomic Neuropathy Predicts All-Cause and Cardiovascular Mortality in Patients With End-Stage Renal Failure: A 5-Year Prospective Study
  54. Pulse wave velocity and cardiac autonomic function in type 2 diabetes mellitus
  55. Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus
  56. Diabetic Foot Infections: an Update in Diagnosis and Management
  57. 7A.10
  58. The effect of consumption of low-glycemic-index and low-glycemic-load desserts on anthropometric parameters and inflammatory markers in patients with type 2 diabetes mellitus
  59. Dry Eye Syndrome in Subjects With Diabetes and Association With Neuropathy: Table 1
  60. A patient with type 2 diabetes and a burning sensation in his feet
  61. Pathogenesis and Treatment of Impaired Wound Healing in Diabetes Mellitus: New Insights
  62. Diabetes Treatment: Recent Developments
  63. Effect of atorvastatin on baroreflex sensitivity in subjects with type 2 diabetes and dyslipidaemia
  64. Incretin-based Therapies for Type 2 Diabetes Mellitus: Effects on Insulin Resistance
  65. The effect of hyperhomocysteinemia on aortic distensibility in healthy individuals
  66. Advances in the Topical Treatment of Diabetic Foot Ulcers
  67. The Role of the Osteoprotegerin/RANKL/RANK System in Diabetic Vascular Disease
  68. Choice of Antihypertensive Treatment in Subjects with Pre-Diabetes. Is There a Dream After the Navigator
  69. Screening for the High-risk Foot of Ulceration: Tests of Somatic and Autonomic Nerve Function
  70. Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections
  71. Acute Hyperhomocysteinemia Impairs Endothelium Function in Subjects with Type 2 Diabetes Mellitus
  72. Moisture Status of the Skin of the Feet Assessed by the Visual Test Neuropad Correlates With Foot Ulceration in Diabetes
  73. Peripheral arterial disease in diabetes-a review
  74. The Effects of Medications Used for the Management of Dyslipidemia on Postprandial Lipemia
  75. The Effects of Medications Used for the Management of Diabetes and Obesity on Postprandial Lipid Metabolism